146 related articles for article (PubMed ID: 38798243)
1. Response to comment on: "Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer".
Janczewski LM; Bentrem DJ; Chawla A
J Surg Oncol; 2024 May; ():. PubMed ID: 38798243
[No Abstract] [Full Text] [Related]
2. Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer.
Janczewski LM; Logan CD; Vitello DJ; Buchheit JT; Abad JD; Bentrem DJ; Chawla A
J Surg Oncol; 2024 Mar; 129(3):481-488. PubMed ID: 37986548
[TBL] [Abstract][Full Text] [Related]
3. Locoregional gastric cancer: a narrative review of multidisciplinary management.
Pelcovits A; Almhanna K
Ann Transl Med; 2020 Sep; 8(17):1108. PubMed ID: 33145327
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Nuccio A; Viscardi G; Salomone F; Servetto A; Venanzi FM; Riva ST; Oresti S; Ogliari FR; Viganò M; Bulotta A; Cameron R; Esposito A; Hines J; Bianco R; Reni M; Cascone T; Garassino MC; Torri V; Veronesi G; Cinquini M; Ferrara R
Eur J Cancer; 2023 Dec; 195():113404. PubMed ID: 37948842
[TBL] [Abstract][Full Text] [Related]
5. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract][Full Text] [Related]
6. Recent updates in perioperative chemotherapy and recurrence pattern of gastric cancer.
Kanaji S; Suzuki S; Matsuda Y; Hasegawa H; Yamamoto M; Yamashita K; Oshikiri T; Matsuda T; Nakamura T; Sumi Y; Kakeji Y
Ann Gastroenterol Surg; 2018 Nov; 2(6):400-405. PubMed ID: 30460342
[TBL] [Abstract][Full Text] [Related]
7. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
8. Comparison of perioperative outcomes among non-small cell lung cancer patients with neoadjuvant immune checkpoint inhibitor plus chemotherapy, EGFR-TKI, and chemotherapy alone: a real-world evidence study.
Zhao D; Xu L; Wu J; She Y; Su H; Hou L; E H; Zhang L; Grossi F; Subramanian MP; Kim AW; Zhu Y; Chen C
Transl Lung Cancer Res; 2022 Jul; 11(7):1468-1478. PubMed ID: 35958337
[TBL] [Abstract][Full Text] [Related]
9. Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.
Sandler S
Oncology (Williston Park); 2014 Jun; 28(6):505-12. PubMed ID: 25134325
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of perioperative and long-term outcomes of laparoscopic versus open gastrectomy for advanced gastric cancer after neoadjuvant therapy: an updated pooled analysis of eighteen studies.
Pang HY; Chen XF; Chen LH; Yan MH; Chen ZX; Sun H
Eur J Med Res; 2023 Jul; 28(1):224. PubMed ID: 37408041
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.
Sun Z; Nussbaum DP; Speicher PJ; Czito BG; Tyler DS; Blazer DG
J Surg Oncol; 2015 Jul; 112(1):46-50. PubMed ID: 26179329
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapy for gastric cancer.
Chadha MK; Kuvshinoff BW; Javle MM
Oncology (Williston Park); 2005 Aug; 19(9):1219-27; discussion 1227-8, 1231-2. PubMed ID: 16255136
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity.
Wu SP; Keshavjee SH; Yoon SS; Kwon S
JAMA Netw Open; 2023 Dec; 6(12):e2349026. PubMed ID: 38127346
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta-analysis.
Bao Y; Ma Z; Yuan M; Wang Y; Men Y; Hui Z
Thorac Cancer; 2022 Sep; 13(17):2515-2523. PubMed ID: 35891585
[TBL] [Abstract][Full Text] [Related]
15. The essentials of locoregional control in the treatment of gastric cancer.
den Dulk M; Verheij M; Cats A; Jansen EP; Hartgrink HH; Van de Velde CJ
Scand J Surg; 2006; 95(4):236-42. PubMed ID: 17249271
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review.
Schirren R; Reim D; Novotny AR
Ther Adv Med Oncol; 2015 Jan; 7(1):39-48. PubMed ID: 25553082
[TBL] [Abstract][Full Text] [Related]
17. Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
Dos Santos M; Lequesne J; Leconte A; Corbinais S; Parzy A; Guilloit JM; Varatharajah S; Brachet PE; Dorbeau M; Vaur D; Weiswald LB; Poulain L; Le Gallic C; Castera-Tellier M; Galais MP; Clarisse B
BMC Cancer; 2022 May; 22(1):537. PubMed ID: 35549674
[TBL] [Abstract][Full Text] [Related]
18. [Exploration and thoughts on perioperative treatment of advanced gastric cancer].
Li YF; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):112-117. PubMed ID: 33508915
[TBL] [Abstract][Full Text] [Related]
19. Comparison of neoadjuvant regimens for resectable gastroesophageal junction cancer: a systematic review of randomized clinical trials across three decades.
Nishikawa G; Banik P; Thawani R; Kardosh A; Wood SG; Nabavizadeh N; Chen EY
J Gastrointest Oncol; 2022 Jun; 13(3):1454-1466. PubMed ID: 35837173
[TBL] [Abstract][Full Text] [Related]
20. [Complete response after neoadjuvant therapy for gastric cancer: implications for surgery].
Capovilla G; Froiio C; Lang H; Berlth F; Grimminger PP
Chirurg; 2022 Feb; 93(2):138-143. PubMed ID: 34622304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
